Get the Stockscreener App
2.885
2.30%
0.065
Codexis Inc stock is traded at $2.885, with a volume of 1.22M.
It is up +2.30% in the last 24 hours and down -5.41% over the past month.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
See More
Previous Close:
$2.82
Open:
$2.88
24h Volume:
1.22M
Relative Volume:
1.24
Market Cap:
$260.42M
Revenue:
$70.14M
Net Income/Loss:
$-76.24M
P/E Ratio:
-2.5991
EPS:
-1.11
Net Cash Flow:
$-57.06M
1W Performance:
-4.15%
1M Performance:
-5.41%
6M Performance:
-30.98%
1Y Performance:
-0.52%
1-Day Range:
$2.86
$3.06
1-Week Range:
$2.735
$3.115
52-Week Range:
$1.90
$6.08
Codexis Inc Stock (CDXS) Company Profile
Name
Codexis Inc
Sector
Industry
Phone
650-421-8100
Address
200 PENOBSCOT DRIVE, REDWOOD CITY, CA
Compare CDXS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDXS
Codexis Inc
|
2.885 | 270.80M | 70.14M | -76.24M | -57.06M | -1.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Codexis Inc Stock (CDXS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-19-24 | Downgrade | The Benchmark Company | Buy → Hold |
| Jun-03-24 | Resumed | Jefferies | Buy |
| May-30-24 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-29-24 | Upgrade | The Benchmark Company | Hold → Buy |
| Nov-07-23 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-07-23 | Downgrade | TD Cowen | Outperform → Market Perform |
| May-09-23 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Mar-31-22 | Resumed | Piper Sandler | Overweight |
| Mar-02-22 | Resumed | Cowen | Outperform |
| Apr-12-21 | Initiated | Piper Sandler | Overweight |
| Mar-01-21 | Initiated | Stifel | Buy |
| Feb-26-21 | Reiterated | H.C. Wainwright | Buy |
| Mar-10-20 | Initiated | The Benchmark Company | Buy |
| Jan-17-19 | Upgrade | First Analysis Sec | Neutral → Outperform |
| May-16-18 | Initiated | Stephens | Overweight |
| Oct-13-17 | Reiterated | H.C. Wainwright | Buy |
| May-31-17 | Initiated | Jefferies | Buy |
| Jan-26-17 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| Jan-04-17 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Jan-06-16 | Initiated | H.C. Wainwright | Buy |
View All
Codexis Inc Stock (CDXS) Latest News
Codexis Inc.’s Price Action Aligns with Quant Signals2025 Pullback Review & Weekly High Potential Alerts - thegnnews.com
Benchmark reiterates Hold rating on Codexis stock after Q2 results - Investing.com
Momentum Screeners Rank Codexis Inc. in Top 5 TodayJuly 2025 Recap & Free Community Supported Trade Ideas - 선데이타임즈
Institutional Tools Highlight Unusual Flow in Codexis Inc.2025 Technical Overview & Fast Entry Momentum Alerts - 선데이타임즈
Codexis, Inc. (NASDAQ:CDXS) Q2 2025 Earnings Call Transcript - MSN
Statistical indicators supporting Codexis Inc.’s strengthWeekly Risk Report & AI Forecast for Swing Trade Picks - Newser
Does Codexis Inc. show high probability of reboundQuarterly Earnings Report & Low Risk High Reward Trade Ideas - Newser
Can a trend reversal in Codexis Inc. lead to recoveryEarnings Summary Report & Accurate Entry/Exit Alerts - Newser
What to expect from Codexis Inc. in the next 30 daysJuly 2025 Recap & AI Powered Market Trend Analysis - Newser
Short interest data insights for Codexis Inc.Trade Entry Summary & Advanced Swing Trade Entry Plans - Newser
Risk adjusted return profile for Codexis Inc. analyzedM&A Rumor & High Accuracy Swing Trade Signals - Newser
Quantitative breakdown of Codexis Inc. recent moveSwing Trade & Risk Managed Investment Strategies - Newser
Codexis Inc. Recovery Potential Based on Technical ToolsBull Run & Daily Volume Surge Trade Alerts - sundaytimes.kr
Codexis Revenue Jumps 91 Percent in Q2 - AOL.com
Can Codexis Inc. Bounce Back From Weekly LowJuly 2025 Price Swings & Low Risk Growth Stock Ideas - classian.co.kr
Codexis reiterates $64M–$68M 2025 revenue guidance while exploring ECO Synthesis expansion - MSN
Chart overlay techniques for tracking Codexis Inc.GDP Growth & Verified Trade Idea Suggestions - Newser
Is Codexis Inc. stock ready for a breakoutWeekly Market Report & Low Risk Entry Point Guides - Newser
Codexis (NASDAQ:CDXS) Upgraded by Wall Street Zen to Hold Rating - Defense World
Price Channel Expanding on Codexis Inc.’s ChartM&A Rumor & Weekly Hot Stock Watchlists - 선데이타임즈
Full technical analysis of Codexis Inc. stockJuly 2025 Price Swings & Weekly Hot Stock Watchlists - Newser
Sector ETF performance correlation with Codexis Inc.Bull Run & Real-Time Chart Breakout Alerts - Newser
Codexis Inc. Nearing Breakout Level After BounceWeekly Profit Analysis & Stepwise Trade Execution Plans - beatles.ru
Published on: 2025-08-15 21:26:42 - newsimpact.co.kr
Codexis Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Codexis Inc. Stock Performance After Earnings: Historical InsightsJuly 2025 Action & Fast Exit and Entry Strategy Plans - Newser
Codexis (CDXS) Reports Q2 Loss, Tops Revenue Estimates - MSN
Codexis Exceeds Q2 2025 Revenue Expectations, Raises $27.3M for ECO Synthesis Expansion - AInvest
Codexis Holdings: A Promising Future Amid Capacity Uncertainties - AInvest
Stifel maintains Buy rating on Codexis stock amid strong business outlook - Investing.com
Cantor Fitzgerald reiterates Overweight rating on Codexis stock, maintains $11 price target - Investing.com Canada
Codexis shares rise 11.48% premarket after reporting strong Q2 revenue and raising $27.3M for ECO Synthesis expansion. - AInvest
Codexis Stock Soars 11.48% on Q2 Earnings Beat - AInvest
Codexis Q2 rev. $15.3mln, up YoY, raises $27.3mln for ECO Synthesis expansion. - AInvest
Codexis 2025 Q2 Earnings 41.7% Net Loss Reduction - AInvest
Codexis: Q2 Earnings Snapshot - Greenwich Time
Codexis Delivers Strong Q2 ResultsCan The Stock Rebound? - RTTNews
Codexis Inc (CDXS) Q2 2025 Earnings Call Highlights: Revenue Surge and Strategic Growth Initiatives - Yahoo Finance
Codexis Inc. Stock Support and Resistance Levels You Should KnowInflation Watch & Target Return Focused Picks - Newser
Codexis Surpasses Expectations with Strong Q2 2025 Results - TipRanks
Codexis Q2 2025: Navigating Contradictions in Revenue Growth, Lab Expansion, and Partnering Strategies - AInvest
Transcript : Codexis, Inc., Q2 2025 Earnings Call, Aug 13, 2025 - MarketScreener
Codexis, Inc. 2025 Q2ResultsEarnings Call Presentation (NASDAQ:CDXS) - Seeking Alpha
Earnings call transcript: Codexis Q2 2025 beats EPS expectations, stock surges - Investing.com Nigeria
Codexis Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Codexis Q2 2025 slides: revenue surges 91%, operating loss narrows significantly By Investing.com - Investing.com South Africa
Codexis Inc (CDXS) Q2 2025 Earnings: Revenue Surpasses Estimates at $15.3 Million, EPS Details Awaited - GuruFocus
Codexis earnings beat by $0.03, revenue topped estimates - Investing.com Canada
Codexis Reports Strong Q2 2025 Revenue of $15.3M and Expands ECO Synthesis® Platform Commitments - Quiver Quantitative
Codexis Reports Second Quarter 2025 Financial Results - The Manila Times
Codexis Inc Stock (CDXS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Codexis Inc Stock (CDXS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. | 10% Owner |
Aug 04 '25 |
Buy |
2.83 |
780 |
2,211 |
12,545,000 |
| Opaleye Management Inc. | 10% Owner |
Jul 29 '25 |
Buy |
2.82 |
8,422 |
23,750 |
12,458,422 |
| Opaleye Management Inc. | 10% Owner |
Jul 30 '25 |
Buy |
2.79 |
1,578 |
4,411 |
12,460,000 |
| Opaleye Management Inc. | 10% Owner |
Jul 18 '25 |
Buy |
2.82 |
100,000 |
282,000 |
12,450,000 |
| Opaleye Management Inc. | 10% Owner |
Jun 27 '25 |
Buy |
2.39 |
100,000 |
239,000 |
12,350,000 |
| Opaleye Management Inc. | 10% Owner |
Jun 12 '25 |
Buy |
2.25 |
100,000 |
225,000 |
12,100,000 |
| Opaleye Management Inc. | 10% Owner |
Jun 13 '25 |
Buy |
2.23 |
99,102 |
220,997 |
12,199,102 |
| Opaleye Management Inc. | 10% Owner |
Jun 16 '25 |
Buy |
2.24 |
50,898 |
114,012 |
12,250,000 |
| Opaleye Management Inc. | 10% Owner |
May 23 '25 |
Buy |
2.36 |
2,320,000 |
5,475,200 |
11,995,000 |
| Opaleye Management Inc. | 10% Owner |
May 28 '25 |
Buy |
2.36 |
5,000 |
11,800 |
12,000,000 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):